The European Patent Office (EPO) has published patent application EP4633611A1, detailing a pharmaceutical composition of Siponimod. The publication date is March 18, 2026, and the applicant is Synthon B.V. This document provides information on the composition and its inventors, indicating a step in the patenting process for this pharmaceutical.

This publication is primarily informational for legal and R&D departments involved in intellectual property and pharmaceutical development. It does not impose new compliance obligations but serves as a notice of patent activity. Companies operating in the pharmaceutical sector, particularly those involved with Siponimod or similar compounds, should note this publication for competitive intelligence and potential licensing or patent challenge considerations.